What is the share price of Unichem Laboratories Ltd (UNICHEMLAB) today?
The share price of UNICHEMLAB as on 20th June 2025 is ₹586.35. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Unichem Laboratories Ltd (UNICHEMLAB) share?
The past returns of Unichem Laboratories Ltd (UNICHEMLAB) share are- Past 1 week: -7.13%
- Past 1 month: -5.13%
- Past 3 months: -11.93%
- Past 6 months: -18.48%
- Past 1 year: 10.12%
- Past 3 years: 142.69%
- Past 5 years: 276.71%
What are the peers or stocks similar to Unichem Laboratories Ltd (UNICHEMLAB)?
The peers or stocks similar to Unichem Laboratories Ltd (UNICHEMLAB) include:What is the market cap of Unichem Laboratories Ltd (UNICHEMLAB) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Unichem Laboratories Ltd (UNICHEMLAB) is ₹4041.99 Cr as of 20th June 2025.What is the 52 week high and low of Unichem Laboratories Ltd (UNICHEMLAB) share?
The 52-week high of Unichem Laboratories Ltd (UNICHEMLAB) is ₹937.95 and the 52-week low is ₹510.20.What is the PE and PB ratio of Unichem Laboratories Ltd (UNICHEMLAB) stock?
The P/E (price-to-earnings) ratio of Unichem Laboratories Ltd (UNICHEMLAB) is 29.39. The P/B (price-to-book) ratio is 1.71.Which sector does Unichem Laboratories Ltd (UNICHEMLAB) belong to?
Unichem Laboratories Ltd (UNICHEMLAB) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Unichem Laboratories Ltd (UNICHEMLAB) shares?
You can directly buy Unichem Laboratories Ltd (UNICHEMLAB) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Unichem Laboratories Ltd
UNICHEMLAB Share Price
586.352.84% (+16.20)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
UNICHEMLAB Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
UNICHEMLAB Performance & Key Metrics
UNICHEMLAB Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 27.94 | 1.71 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 35.65 | 6.55 | 0.83% |
UNICHEMLAB Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
UNICHEMLAB Company Profile
Unichem Laboratories Limited is a pharmaceutical company that manufactures active pharmaceutical ingredients (APIs or bulk actives).
SUNPHARMA
PE Ratio
36.18
36.18
1Y Return
13.20%
13.20%
Buy Reco %
87.88
87.88
CIPLA
PE Ratio
22.95
22.95
1Y Return
2.92%
2.92%
Buy Reco %
74.19
74.19
DRREDDY
PE Ratio
19.32
19.32
1Y Return
10.98%
10.98%
Buy Reco %
56.67
56.67
TORNTPHARM
PE Ratio
57.15
57.15
1Y Return
10.81%
10.81%
Buy Reco %
72.00
72.00
MANKIND
PE Ratio
48.88
48.88
1Y Return
4.22%
4.22%
Buy Reco %
81.25
81.25
UNICHEMLAB Forecast
UNICHEMLAB Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
UNICHEMLAB
UNICHEMLAB
Income
Balance Sheet
Cash Flow
Annual Normal View
UNICHEMLAB Income Statement
UNICHEMLAB Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 882.81 | 3,553.47 | 1,280.29 | 1,195.84 | 1,285.33 | 1,317.34 | 1,381.54 | 1,804.50 | 2,146.29 | 2,109.48 | ||||||||||
Raw Materials | 262.42 | 387.73 | 477.13 | 422.92 | 467.52 | 457.36 | 533.73 | 743.72 | 1,846.11 | 1,805.86 | ||||||||||
| Power & Fuel Cost | 41.62 | 49.23 | 76.39 | 73.02 | 68.89 | 78.05 | 102.84 | 107.14 | ||||||||||||
| Employee Cost | 169.04 | 200.64 | 238.52 | 273.28 | 306.97 | 330.49 | 356.41 | 393.06 | ||||||||||||
| Selling & Administrative Expenses | 233.92 | 291.18 | 420.94 | 345.54 | 316.35 | 287.13 | 299.84 | 361.41 | ||||||||||||
| Operating & Other expenses | 32.10 | 17.93 | 50.56 | 39.77 | -15.36 | 45.07 | 134.33 | 124.94 | ||||||||||||
EBITDA | 143.71 | 2,606.76 | 16.75 | 41.31 | 140.96 | 119.24 | -45.61 | 74.23 | 300.18 | 303.62 | ||||||||||
| Depreciation/Amortization | 43.52 | 50.51 | 67.37 | 81.67 | 84.36 | 91.17 | 113.44 | 113.24 | 124.56 | 120.82 | ||||||||||
| PBIT | 100.19 | 2,556.25 | -50.62 | -40.36 | 56.60 | 28.07 | -159.05 | -39.01 | 175.62 | 182.80 | ||||||||||
| Interest & Other Items | 3.36 | 8.01 | 7.52 | 7.85 | 5.12 | 6.11 | 17.31 | 22.66 | 21.03 | 21.03 | ||||||||||
| PBT | 96.83 | 2,548.24 | -58.14 | -48.21 | 51.48 | 21.96 | -176.36 | -61.67 | 154.59 | 161.77 | ||||||||||
| Taxes & Other Items | -11.85 | 3.34 | -34.35 | 11.97 | 17.15 | -11.09 | 25.86 | 8.80 | 17.07 | 17.08 | ||||||||||
| Net Income | 108.68 | 2,544.90 | -23.79 | -60.18 | 34.33 | 33.05 | -202.22 | -70.47 | 137.52 | 144.69 | ||||||||||
| EPS | 11.96 | 315.72 | -3.38 | -8.55 | 4.88 | 4.69 | -28.72 | -10.01 | 19.53 | 20.55 | ||||||||||
| DPS | 3.00 | 5.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.25 | 0.02 | — | — | 0.82 | 0.85 | — | 0.00 | 0.00 | 0.00 |
UNICHEMLAB Company Updates
UNICHEMLAB Stock Peers
UNICHEMLAB Past Performance & Peer Comparison
UNICHEMLAB Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Unichem Laboratories Ltd | 29.39 | 1.71 | — |
| Sun Pharmaceutical Industries Ltd | 36.18 | 5.89 | 0.97% |
| Cipla Ltd | 22.95 | 4.51 | 1.07% |
| Dr Reddy's Laboratories Ltd | 19.32 | 3.87 | 0.61% |
UNICHEMLAB Stock Price Comparison
Compare UNICHEMLAB with any stock or ETFCompare UNICHEMLAB with any stock or ETF
UNICHEMLAB
UNICHEMLAB Holdings
UNICHEMLAB Shareholdings
UNICHEMLAB Promoter Holdings Trend
UNICHEMLAB Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
UNICHEMLAB Institutional Holdings Trend
UNICHEMLAB Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
UNICHEMLAB Shareholding Pattern
UNICHEMLAB Shareholding Pattern
UNICHEMLAB Shareholding History
UNICHEMLAB Shareholding History
Foreign Institutions
Mutual Funds Invested in UNICHEMLAB
Mutual Funds Invested in UNICHEMLAB
Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Unichem Laboratories Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 8.1000% | Percentage of the fund’s portfolio invested in the stock 0.96% | Change in the portfolio weight of the stock over the last 3 months -0.22% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 44/89 (-9) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.2610% | Percentage of the fund’s portfolio invested in the stock 1.72% | Change in the portfolio weight of the stock over the last 3 months -0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 19/34 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.3567% | Percentage of the fund’s portfolio invested in the stock 0.26% | Change in the portfolio weight of the stock over the last 3 months -0.08% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 46/47 (0) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing UNICHEMLAB stock
smallcases containing UNICHEMLAB stock
Looks like this stock is not in any smallcase yet.
UNICHEMLAB Events
UNICHEMLAB Events
UNICHEMLAB Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
UNICHEMLAB Dividend Trend
No dividend trend available
UNICHEMLAB Upcoming Dividends
UNICHEMLAB Upcoming Dividends
No upcoming dividends are available
UNICHEMLAB Past Dividends
UNICHEMLAB Past Dividends
Cash Dividend
Ex DateEx DateAug 1, 2022
Final
Final | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
Aug 1, 2022
Cash Dividend
Ex DateEx DateJul 22, 2021
Final
Final | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
Jul 22, 2021
Cash Dividend
Ex DateEx DateAug 20, 2020
Final
Final | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
Aug 20, 2020
Cash Dividend
Ex DateEx DateJul 18, 2019
Final
Final | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
Jul 18, 2019
Cash Dividend
Ex DateEx DateJul 19, 2018
Final
Final | Div/Share: ₹5.00
Dividend/Share
₹5.00
Ex DateEx Date
Jul 19, 2018
UNICHEMLAB Stock News & Opinions
UNICHEMLAB Stock News & Opinions
Articles & Videos
Corporate
Unichem Laboratories to convene AGM
Unichem Laboratories announced that the 62th Annual General Meeting(AGM) of the company will be held on 4 August 2025.Powered by Capital Market - Live
46 minutes agoCapital Market - Live
Earnings
Unichem Laboratories reports consolidated net profit of Rs 52.97 crore in the March 2025 quarter
Net profit of Unichem Laboratories reported to Rs 52.97 crore in the quarter ended March 2025 as against net loss of Rs 129.31 crore during the previous quarter ended March 2024. Sales rose 36.02% to Rs 587.18 crore in the quarter ended March 2025 as against Rs 431.70 crore during the previous quarter ended March 2024. For the full year,net profit reported to Rs 137.52 crore in the year ended March 2025 as against net loss of Rs 93.76 crore during the previous year ended March 2024. Sales rose 18.25% to Rs 2110.97 crore in the year ended March 2025 as against Rs 1785.11 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales587.18431.70 36 2110.971785.11 18 OPM %14.255.87 -12.554.87 - PBDT87.4926.91 225 279.1595.81 191 PBT57.80-0.25 LP 154.59-27.35 LP NP52.97-129.31 LP 137.52-93.76 LP Powered by Capital Market - Live
4 weeks agoCapital Market - Live
Corporate
Unichem Laboratories to table results
Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 22 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Unichem Laboratories receives update in credit ratings from ICRA
Unichem Laboratories announced that t ICRA, the credit rating agency has upgraded the rating to [ICRA] A+ from [ICRA] A assigned earlier to the Rs. 180.0 crore bank facilities of the Company. Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Unichem Laboratories consolidated net profit declines 20.99% in the December 2024 quarter
Net profit of Unichem Laboratories declined 20.99% to Rs 57.85 crore in the quarter ended December 2024 as against Rs 73.22 crore during the previous quarter ended December 2023. Sales rose 14.47% to Rs 533.09 crore in the quarter ended December 2024 as against Rs 465.72 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales533.09465.72 14 OPM %16.046.68 - PBDT92.3936.81 151 PBT61.855.19 1092 NP57.8573.22 -21 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Unichem Laboratories schedules board meeting
Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 6 February 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Unichem Laboratories reports consolidated net profit of Rs 30.49 crore in the September 2024 quarter
Net profit of Unichem Laboratories reported to Rs 30.49 crore in the quarter ended September 2024 as against net loss of Rs 24.49 crore during the previous quarter ended September 2023. Sales rose 11.20% to Rs 462.16 crore in the quarter ended September 2024 as against Rs 415.63 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales462.16415.63 11 OPM %12.452.11 - PBDT61.537.57 713 PBT32.99-21.88 LP NP30.49-24.49 LP Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Unichem Laboratories to discuss results
Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Unichem Laboratories to hold board meeting
Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 30 September 2024.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Board of Unichem Laboratories to consider proposal for consolidation of generic formulations biz in US
The Board of Unichem Laboratories will meet on 30 September 2024 to consider and approve integration and consolidation of the generics formulations business in the US market of M/s. Bayshore Pharmaceuticals LLC (wholly owned subsidiary of Company's holding company, Ipca Laboratories) into Unichem Pharmaceuticals (USA) Inc. (company's wholly owned subsidiary) so as to consolidate all the Ipca Group's USA generics formulations business under one entity.Powered by Capital Market - Live
8 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 7.1%, vs industry avg of 9.03%
Over the last 5 years, market share decreased from 0.58% to 0.47%